AbbVie
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
CEORichard A. Gonzalez
CEORichard A. Gonzalez
Employees50,000
Employees50,000
HeadquartersNorth Chicago, Illinois
HeadquartersNorth Chicago, Illinois
Founded2011
Founded2011
Employees50,000
Employees50,000
ABBV Key Statistics
Market cap315.37B
Market cap315.37B
Price-Earnings ratio65.43
Price-Earnings ratio65.43
Dividend yield3.37%
Dividend yield3.37%
Average volume7.67M
Average volume7.67M
High today$179.74
High today$179.74
Low today$177.58
Low today$177.58
Open price$179.01
Open price$179.01
Volume8.57M
Volume8.57M
52 Week high$182.89
52 Week high$182.89
52 Week low$130.96
52 Week low$130.96
ABBV News
Yahoo Finance 6d
Why AbbVie Dipped More Than Broader Market Today - Yahoo FinanceIn the latest trading session, AbbVie (ABBV) closed at $179.86, marking a -0.59% move from the previous day. The stock fell short of the S&P 500, which register...
Analyst ratings
57%
of 30 ratingsBuy
56.7%
Hold
43.3%
Sell
0%